BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arteh J, Narra S, Nair S. Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci 2010;55:2624-8. [PMID: 19960254 DOI: 10.1007/s10620-009-1069-9] [Cited by in Crossref: 254] [Cited by in F6Publishing: 247] [Article Influence: 19.5] [Reference Citation Analysis]
Number Citing Articles
1 Pop TL, Sîrbe C, Benţa G, Mititelu A, Grama A. The Role of Vitamin D and Vitamin D Binding Protein in Chronic Liver Diseases. IJMS 2022;23:10705. [DOI: 10.3390/ijms231810705] [Reference Citation Analysis]
2 Ravaioli F, Pivetti A, Di Marco L, Chrysanthi C, Frassanito G, Pambianco M, Sicuro C, Gualandi N, Guasconi T, Pecchini M, Colecchia A. Role of Vitamin D in Liver Disease and Complications of Advanced Chronic Liver Disease. Int J Mol Sci 2022;23:9016. [PMID: 36012285 DOI: 10.3390/ijms23169016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Harahap IA, Landrier J, Suliburska J. Interrelationship between Vitamin D and Calcium in Obesity and Its Comorbid Conditions. Nutrients 2022;14:3187. [DOI: 10.3390/nu14153187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Majety P, Groysman A, Erlikh N, Chen ZZ, Westcott GP. Predictors of mortality in hypercalcemia of advanced chronic liver disease. Endocr Pract 2022:S1530-891X(22)00567-5. [PMID: 35868607 DOI: 10.1016/j.eprac.2022.07.008] [Reference Citation Analysis]
5 Curakova Ristovska E, Genadieva-Dimitrova M. Prognostic value of von-Willebrand factor in patients with liver cirrhosis and its relation to other prognostic indicators. World J Hepatol 2022; 14(4): 812-826 [DOI: 10.4254/wjh.v14.i4.812] [Reference Citation Analysis]
6 Pigarova EA, Dzeranova LК, Yatsenko DA. Absorption and metabolism of vitamin D in health and in gastrointestinal tract diseases. Obes metabol 2022;19:123-133. [DOI: 10.14341/omet12835] [Reference Citation Analysis]
7 Bania A, Pitsikakis K, Mavrovounis G, Mermiri M, Beltsios ET, Adamou A, Konstantaki V, Makris D, Tsolaki V, Gourgoulianis K, Pantazopoulos I. Therapeutic Vitamin D Supplementation Following COVID-19 Diagnosis: Where Do We Stand?—A Systematic Review. JPM 2022;12:419. [DOI: 10.3390/jpm12030419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Zaidi M, Yuen T, Iqbal J. Reverse cholesterol transport and hepatic osteodystrophy. Cell Metab 2022;34:347-9. [PMID: 35235770 DOI: 10.1016/j.cmet.2022.02.007] [Reference Citation Analysis]
9 Siqueira MDMLG, Casulari LA, Freitas WMD, Carneiro MDV, Mendes LSC. RISK FACTORS ASSOCIATED WITH FRACTURE OF THE LUMBOSACRAL SPINE AND ITS COMPROMISE IN THE QUALITY OF LIFE OF CIRRHOTICS. Arq Gastroenterol 2022;59:9-15. [DOI: 10.1590/s0004-2803.202200001-03] [Reference Citation Analysis]
10 Gougol A, Behari J. Biomarkers of Malnutrition in Cirrhosis. Biomarkers in Disease: Methods, Discoveries and Applications 2022. [DOI: 10.1007/978-3-031-07389-2_43] [Reference Citation Analysis]
11 Gougol A, Behari J. Biomarkers of Malnutrition in Cirrhosis. Biomarkers in Disease: Methods, Discoveries and Applications 2022. [DOI: 10.1007/978-3-030-81304-8_43-1] [Reference Citation Analysis]
12 Zhu W, Ding Q, Wang L, Xu G, Diao Y, Qu S, Chen S, Shi Y. Vitamin D3 alleviates pulmonary fibrosis by regulating the MAPK pathway via targeting PSAT1 expression in vivo and in vitro. Int Immunopharmacol 2021;101:108212. [PMID: 34656907 DOI: 10.1016/j.intimp.2021.108212] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Grover I, Gunjan D, Singh N, Benjamin J, Ramakrishnan L, Pandey RM, Sati HC, Saraya A. Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: A Randomized Clinical Trial. Am J Gastroenterol 2021;116:2098-104. [PMID: 33927126 DOI: 10.14309/ajg.0000000000001272] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Bakaloudi DR, Chourdakis M. A critical update on the role of mild and serious vitamin D deficiency prevalence and the COVID-19 epidemic in Europe. Nutrition 2022;93:111441. [PMID: 34492624 DOI: 10.1016/j.nut.2021.111441] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
15 Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S, Carey EJ. Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1611-44. [PMID: 34233031 DOI: 10.1002/hep.32049] [Cited by in Crossref: 79] [Cited by in F6Publishing: 61] [Article Influence: 39.5] [Reference Citation Analysis]
16 Chai W, Eaton S, Rasmussen HE, Tao MH. Associations of Dietary Lipid-Soluble Micronutrients with Hepatic Steatosis among Adults in the United States. Biomedicines 2021;9:1093. [PMID: 34572279 DOI: 10.3390/biomedicines9091093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Bjelakovic M, Nikolova D, Bjelakovic G, Gluud C. Vitamin D supplementation for chronic liver diseases in adults. Cochrane Database Syst Rev 2021;8:CD011564. [PMID: 34431511 DOI: 10.1002/14651858.CD011564.pub3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
18 Uçmak F, Yılmaz A, Ekin N, Ekinci A, Solmaz İ, Şenateş E. Vitamin D deficiency in patients with chronic hepatitis D viral infection. Clin Exp Hepatol 2021;7:141-8. [PMID: 34295980 DOI: 10.5114/ceh.2021.106505] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Nelson JA, Mortensen MJ, Horslen S, Bhat AH. Impact of nutritional status on prevalence of left ventricular hypertrophy in children undergoing liver transplant. Pediatr Transplant 2021;25:e14011. [PMID: 34004058 DOI: 10.1111/petr.14011] [Reference Citation Analysis]
20 Abdel Hafez H, Madani H, Abdel Alem S, Farrag A, Fathy W, Abdo M. Is Serum-Ascites Vitamin D Gradient a Valid Marker for Diagnosing Spontaneous Bacterial Peritonitis in Patients with Cirrhotic Ascites? Lab Med 2021:lmab019. [PMID: 33939819 DOI: 10.1093/labmed/lmab019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Zelber-Sagi S, Ivancovsky-Wajcman D, Rabinowich L, Bentov I, Deutsch L. Nutritional Evaluation and Treatment of the Cirrhotic Patient. Clin Liver Dis 2021;25:373-92. [PMID: 33838856 DOI: 10.1016/j.cld.2021.01.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Bukhari T, Jafri L, Majid H, Khan AHH, Siddiqui I. Determining Bone Turnover Status in Patients With Chronic Liver Disease. Cureus 2021;13:e14479. [PMID: 33996337 DOI: 10.7759/cureus.14479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 He J, Du J, Yi B, Wang J, Zhang H, Li YC, Sun J. MicroRNA-122 contributes to lipopolysaccharide-induced acute kidney injury via down-regulating the vitamin D receptor in the kidney. Eur J Clin Invest 2021;51:e13547. [PMID: 33782973 DOI: 10.1111/eci.13547] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Makris K, Bhattoa HP, Cavalier E, Phinney K, Sempos CT, Ulmer CZ, Vasikaran SD, Vesper H, Heijboer AC. Recommendations on the measurement and the clinical use of vitamin D metabolites and vitamin D binding protein - A position paper from the IFCC Committee on bone metabolism. Clin Chim Acta 2021;517:171-97. [PMID: 33713690 DOI: 10.1016/j.cca.2021.03.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
25 Bakaloudi DR, Chourdakis M. Prevalence of vitamin D is not associated with the COVID-19 epidemic in Europe. A critical update of the existing evidence.. [DOI: 10.1101/2021.03.04.21252885] [Reference Citation Analysis]
26 Afifi MAE, Hussein AM, Rizk M. Low Serum 25-Hydroxy Vitamin D (25-OHD) and Hepatic Encephalopathy in HCV-Related Liver Cirrhosis. Int J Hepatol 2021;2021:6669527. [PMID: 33628512 DOI: 10.1155/2021/6669527] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Sriphoosanaphan S, Thanapirom K, Kerr SJ, Suksawatamnuay S, Thaimai P, Sittisomwong S, Sonsiri K, Srisoonthorn N, Teeratorn N, Tanpowpong N, Chaopathomkul B, Treeprasertsuk S, Poovorawan Y, Komolmit P. Effect of vitamin D supplementation in patients with chronic hepatitis C after direct-acting antiviral treatment: a randomized, double-blind, placebo-controlled trial. PeerJ 2021;9:e10709. [PMID: 33614272 DOI: 10.7717/peerj.10709] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
28 Hey P, Gow P, Testro AG, Apostolov R, Chapman B, Sinclair M. Nutraceuticals for the treatment of sarcopenia in chronic liver disease. Clin Nutr ESPEN 2021;41:13-22. [PMID: 33487256 DOI: 10.1016/j.clnesp.2020.11.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
29 Dharmarajan TS. Vitamin D. Geriatric Gastroenterology 2021. [DOI: 10.1007/978-3-030-30192-7_23] [Reference Citation Analysis]
30 Ağalar H. Influence of vitamins (C, B3, D, and E) in liver health. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases 2021. [DOI: 10.1016/b978-0-12-816488-4.00009-7] [Reference Citation Analysis]
31 Dharmarajan TS. Vitamin D. Geriatric Gastroenterology 2021. [DOI: 10.1007/978-3-319-90761-1_23-1] [Reference Citation Analysis]
32 Fatima I, Aslam M, Asif H, Kabir M, Hayee S. Nutritional Assessment of Liver Cirrhosis Patients Visiting Public Hospital, Lahore. DF 2020. [DOI: 10.54393/df.v1i02.33] [Reference Citation Analysis]
33 Saeki C, Kanai T, Nakano M, Oikawa T, Torisu Y, Saruta M, Tsubota A. Low Serum 25-Hydroxyvitamin D Levels Are Related to Frailty and Sarcopenia in Patients with Chronic Liver Disease. Nutrients 2020;12:E3810. [PMID: 33322706 DOI: 10.3390/nu12123810] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
34 Behairy OG, Abo Amer ARA, Mansour AI, Mohamed KI. Association between vitamin D status and depression in children with chronic liver disease. Egypt Liver Journal 2020;10:34. [DOI: 10.1186/s43066-020-00042-y] [Reference Citation Analysis]
35 Gad AI, Elmedames MR, Abdelhai AR, Marei AM. The association between vitamin D status and non-alcoholic fatty liver disease in adults: a hospital-based study. Egypt Liver Journal 2020;10:25. [DOI: 10.1186/s43066-020-00033-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
36 Doi J, Moro A, Fujiki M, Eghtesad B, Quintini C, Menon KVN, Hashimoto K, Sasaki K. Nutrition Support in Liver Transplantation and Postoperative Recovery: The Effects of Vitamin D Level and Vitamin D Supplementation in Liver Transplantation. Nutrients 2020;12:E3677. [PMID: 33260597 DOI: 10.3390/nu12123677] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
37 Zhang R, Fu Z, Fan H, Tian T, Wu M, Xie C, Huang P, Yu R, Zhang Y, Zhang W, Wang J. Genetic variant of RXR involved in the vitamin D metabolic pathway was linked to HCV infection outcomes among a high-risk Chinese population. Infect Genet Evol 2021;87:104641. [PMID: 33246082 DOI: 10.1016/j.meegid.2020.104641] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
38 Yuan F, Xu Y, You K, Zhang J, Yang F, Li YX. Calcitriol alleviates ethanol-induced hepatotoxicity via AMPK/mTOR-mediated autophagy. Arch Biochem Biophys 2021;697:108694. [PMID: 33232716 DOI: 10.1016/j.abb.2020.108694] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
39 Osei-Bordom D, Bozward AG, Oo YH. The hepatic microenvironment and regulatory T cells. Cell Immunol 2020;357:104195. [PMID: 32861844 DOI: 10.1016/j.cellimm.2020.104195] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
40 Zhang Y, Jiang X, Li X, Găman MA, Kord-Varkaneh H, Rahmani J, Salehi-Sahlabadi A, Day AS, Xu Y. Serum Vitamin D Levels and Risk of Liver Cancer: A Systematic Review and Dose-Response Meta-Analysis of Cohort Studies. Nutr Cancer 2021;73:1-9. [PMID: 32705896 DOI: 10.1080/01635581.2020.1797127] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
41 Mehta CH, Close MF, Dornhoffer JR, Liu YF, Nguyen SA, McRackan TR, Meyer TA. Vitamin D Deficiency, Hypocalcemia, and Hearing Loss in Children. Otol Neurotol 2020;41:940-7. [PMID: 32658400 DOI: 10.1097/MAO.0000000000002676] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Fang AP, Long JA, Zhang YJ, Liu ZY, Li QJ, Zhang DM, Luo Y, Zhong RH, Zhou ZG, Xu YJ, Xu XJ, Ling WH, Chen MS, Zhu HL. Serum Bioavailable, Rather Than Total, 25-hydroxyvitamin D Levels Are Associated With Hepatocellular Carcinoma Survival. Hepatology 2020;72:169-82. [PMID: 31677282 DOI: 10.1002/hep.31013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
43 Triantos C, Kalafateli M, Aggeletopoulou I, Diamantopoulou G, Spantidea PI, Michalaki M, Vourli G, Konstantakis C, Assimakopoulos SF, Manolakopoulos S, Gogos C, Kyriazopoulou V, Mouzaki A, Thomopoulos K. Vitamin D-related immunomodulation in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 2020;32:867-76. [PMID: 31789949 DOI: 10.1097/MEG.0000000000001597] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
44 He X, Xu C, Lu ZH, Fang XZ, Tan J, Song Y. Low serum 25-hydroxyvitamin D levels are associated with liver injury markers in the US adult population. Public Health Nutr 2020;23:2915-22. [PMID: 32576302 DOI: 10.1017/S1368980020000348] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
45 Kumar P, Chaudhry S, Dev N, Kumar R, Singh G. Serum 25-hydroxyvitamin D level in patients with chronic liver disease and its correlation with hepatic encephalopathy: A cross-sectional study. J Family Med Prim Care 2020;9:798-803. [PMID: 32318423 DOI: 10.4103/jfmpc.jfmpc_1084_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 Ko WS, Yang YP, Shen FP, Wu MC, Shih CJ, Lu MC, Yan YH, Chiou YL. The Study of Correlation Between Serum Vitamin D3 Concentrations and HBV DNA Levels and Immune Response in Chronic Hepatitis Patients. Nutrients 2020;12:E1114. [PMID: 32316365 DOI: 10.3390/nu12041114] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
47 Ko WS, Shen FP, Shih CJ, Chiou YL. The 25(OH)Vitamin D Status Affected the Effectiveness of Oligo Fucoidan in Patients with Chronic Hepatitis B Virus Infection with Immune Tolerance Phase. Nutrients 2020;12:E321. [PMID: 31991892 DOI: 10.3390/nu12020321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
48 Colak R, Anil M, Yasar F, Rahmi Bakiler A, Pirgon O, Helvaci M, Dündar B. Metabolic disturbances and cardiovascular risk factors in obese children with vitamin D deficiency. Arch Pediatr 2020;27:140-5. [PMID: 31955958 DOI: 10.1016/j.arcped.2019.12.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
49 Makris K, Sempos C, Cavalier E. The measurement of vitamin D metabolites: part I-metabolism of vitamin D and the measurement of 25-hydroxyvitamin D. Hormones (Athens) 2020;19:81-96. [PMID: 31919677 DOI: 10.1007/s42000-019-00169-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
50 Cervantes-pérez E, Cervantes-Guevara, Cervantes-pérez L, Cervantes-pérez G, Cervantes-Cardona, Ramírez-ochoa S, Martínez-soto holguín M, González-ojeda A, Fuentes-orozco, Sosa-pérez R, Ruiz-Gallardo, Villaseñor-ochoa A, Robledo-valdez, Ramírez-casale. Estado actual del manejo nutricional en pacientes con trasplante hepático. Revista Mexicana de Trasplantes 2020;9:74-81. [DOI: 10.35366/95710] [Reference Citation Analysis]
51 Völker D, Grünhage F, Wagenpfeil S, Lammert F, Stokes CS. Serum 25-hydroxyvitamin D levels and mortality risk in patients with liver cirrhosis: a protocol for a systematic review and meta-analysis of observational studies. Syst Rev 2019;8:73. [DOI: 10.1186/s13643-019-0988-6] [Reference Citation Analysis]
52 Zhuang P, Sun S, Dong R, Chen G, Huang Y, Zheng S. Associations between Vitamin D and Liver Function and Liver Fibrosis in Patients with Biliary Atresia. Gastroenterol Res Pract 2019;2019:4621372. [PMID: 31781188 DOI: 10.1155/2019/4621372] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
53 Kurtoğlu E, Uğur Kurtoğlu A, Koçtekin B, Uğur S, Bozkurt S. Association between serum vitamin D level and liver MRI T2 star in patients with β-thalassemia major. Turkish Journal of Biochemistry 2019;44:594-598. [DOI: 10.1515/tjb-2018-0120] [Reference Citation Analysis]
54 Zhou Q, Li L, Chen Y, Zhang J, Zhong L, Peng Z, Xing T. Vitamin D supplementation could reduce the risk of acute cellular rejection and infection in vitamin D deficient liver allograft recipients. International Immunopharmacology 2019;75:105811. [DOI: 10.1016/j.intimp.2019.105811] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
55 Fu L, Cui H, Lu K, Zou C, Ji G, Li L, Li J, Sheng L, Xie C. [Correlation between serum 25(OH) vitamin D and liver fat content in nonalcoholic fatty liver disease]. Nan Fang Yi Ke Da Xue Xue Bao 2019;39:1118-21. [PMID: 31640966 DOI: 10.12122/j.issn.1673-4254.2019.09.19] [Reference Citation Analysis]
56 Thanapirom K, Suksawatamnuay S, Sukeepaisarnjaroen W, Tangkijvanich P, Thaimai P, Wasitthankasem R, Poovorawan Y, Komolmit P. Genetic associations of vitamin D receptor polymorphisms with advanced liver fibrosis and response to pegylated interferon-based therapy in chronic hepatitis C. PeerJ 2019;7:e7666. [PMID: 31565578 DOI: 10.7717/peerj.7666] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
57 Reiter FP, Ye L, Bösch F, Wimmer R, Artmann R, Ziesch A, Kanitz V, Mayr D, Steib CJ, Trauner M, Regel I, Gerbes AL, Mayerle J, Hohenester S, de Toni EN, Denk G. Antifibrotic effects of hypocalcemic vitamin D analogs in murine and human hepatic stellate cells and in the CCl4 mouse model. Lab Invest 2019;99:1906-17. [PMID: 31467426 DOI: 10.1038/s41374-019-0310-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
58 El Sayed Zeid A, El Sayed Salem P, El Hadidi AS, Ibrahim TG. Vitamin D and LL-37 in cirrhotic patients with culture-positive spontaneous bacterial peritonitis. Egypt J Intern Med 2019;31:247-53. [DOI: 10.4103/ejim.ejim_102_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
59 Palmer LB, Kuftinec G, Pearlman M, Green CH. Nutrition in Cirrhosis. Curr Gastroenterol Rep. 2019;21:38. [PMID: 31289936 DOI: 10.1007/s11894-019-0706-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
60 Wu Y, Fan W, Xue M, Guo J, Wei J, Wang Y, Yao W, Zhao Y, Li J. 25-OH-vitamin D deficiency identifies poor tumor response in hepatocellular carcinoma treated with transarterial chemoembolization. Clin Transl Oncol 2020;22:70-80. [DOI: 10.1007/s12094-019-02146-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
61 Palazzo D, Biliotti E, Esvan R, Volpicelli L, Franchi C, Fontanelli Sulekova L, Spaziante M, Santori M, Rugova A, Rucci P, Taliani G. Vitamin D deficiency and health-related quality of life in chronic hepatitis C. J Viral Hepat 2019;26:774-7. [PMID: 30739371 DOI: 10.1111/jvh.13076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
62 Ehnert S, Aspera-Werz RH, Ruoß M, Dooley S, Hengstler JG, Nadalin S, Relja B, Badke A, Nussler AK. Hepatic Osteodystrophy-Molecular Mechanisms Proposed to Favor Its Development. Int J Mol Sci 2019;20:E2555. [PMID: 31137669 DOI: 10.3390/ijms20102555] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
63 Sangouni AA, Ghavamzadeh S, Jamalzehi A. A narrative review on effects of vitamin D on main risk factors and severity of Non-Alcoholic Fatty Liver Disease. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019;13:2260-5. [DOI: 10.1016/j.dsx.2019.05.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
64 Thanapirom K, Suksawatamnuay S, Sukeepaisarnjaroen W, Treeprasertsuk S, Tanwandee T, Charatcharoenwitthaya P, Thongsawat S, Leerapun A, Piratvisuth T, Boonsirichan R, Bunchorntavakul C, Pattanasirigool C, Pornthisarn B, Tuntipanichteerakul S, Sripariwuth E, Jeamsripong W, Sanpajit T, Poovorawan Y, Komolmit P. Vitamin D-Binding protein Gene Polymorphism Predicts Pegylated Interferon-Related HBsAg Seroclearance in HBeAg-Negative Thai Chronic Hepatitis B Patients: A Multicentre Study. Asian Pac J Cancer Prev 2019;20:1257-64. [PMID: 31030503 DOI: 10.31557/APJCP.2019.20.4.1257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
65 Barooah P, Saikia S, Bharadwaj R, Sarmah P, Bhattacharyya M, Goswami B, Medhi S. Role of VDR, GC, and CYP2R1 Polymorphisms in the Development of Hepatocellular Carcinoma in Hepatitis C Virus-Infected Patients. Genet Test Mol Biomarkers 2019;23:325-31. [PMID: 30942619 DOI: 10.1089/gtmb.2018.0170] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
66 Mohamed AA, Abd Almonaem ER, Mansour AI, Algebaly HF, Khattab RA, El Abd YS. Importance of Studying the Levels of Hepcidin and Vitamin D in Egyptian Children with Chronic Hepatitis C. J Transl Int Med 2019;7:15-21. [PMID: 30997352 DOI: 10.2478/jtim-2019-0004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
67 Narayanasamy K, Karthick R, Raj AK. High Prevalent Hypovitaminosis D Is Associated with Dysregulation of Calcium-parathyroid Hormone-vitamin D Axis in Patients with Chronic Liver Diseases. J Clin Transl Hepatol 2019;7:15-20. [PMID: 30944814 DOI: 10.14218/JCTH.2018.00018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
68 Licata A, Minissale MG, Montalto FA, Soresi M. Is vitamin D deficiency predictor of complications development in patients with HCV-related cirrhosis? Intern Emerg Med 2019;14:735-7. [PMID: 30879232 DOI: 10.1007/s11739-019-02072-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
69 Behera MK, Shukla SK, Dixit VK, Nath P, Abhilash VB, Asati PK, Jain AK. Effect of vitamin D supplementation on sustained virological response in genotype 1/4 chronic hepatitis C treatment-naïve patients from India. Indian J Med Res 2018;148:200-6. [PMID: 30381543 DOI: 10.4103/ijmr.IJMR_1295_15] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
70 Pacifico L, Osborn JF, Bonci E, Pierimarchi P, Chiesa C. Association between Vitamin D Levels and Nonalcoholic Fatty Liver Disease: Potential Confounding Variables. Mini Rev Med Chem 2019;19:310-32. [PMID: 30360708 DOI: 10.2174/1389557518666181025153712] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
71 Yeung C. Fat-soluble vitamin deficiency in pediatric patients with chronic liver disease. Pediatrics & Neonatology 2019;60:1-2. [DOI: 10.1016/j.pedneo.2019.01.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
72 Czaja AJ, Montano-Loza AJ. Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis. Dig Dis Sci 2019;64:324-44. [PMID: 30370494 DOI: 10.1007/s10620-018-5351-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
73 Yousif MM, Sadek AMEM, Farrag HA, Selim FO, Hamed EF, Salama RI. Associated vitamin D deficiency is a risk factor for the complication of HCV-related liver cirrhosis including hepatic encephalopathy and spontaneous bacterial peritonitis. Intern Emerg Med 2019;14:753-61. [PMID: 30706253 DOI: 10.1007/s11739-019-02042-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
74 Kim HY, Kim JH, Jung MH, Cho IA, Kim Y, Cho MC. Clinical Usefulness of Bioavailable Vitamin D and Impact of GC Genotyping on the Determination of Bioavailable Vitamin D in a Korean Population. Int J Endocrinol 2019;2019:9120467. [PMID: 30774661 DOI: 10.1155/2019/9120467] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
75 Ebadi M, Bhanji RA, Mazurak VC, Lytvyak E, Mason A, Czaja AJ, Montano-Loza AJ. Severe vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis. Aliment Pharmacol Ther 2019;49:173-82. [PMID: 30484857 DOI: 10.1111/apt.15029] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 9.0] [Reference Citation Analysis]
76 Gürbüz F, Ağın M, Mengen E, Elçi H, Ünal İ, Tümgör G, Yüksel B. Kronik karaciğer hastalığı olan çocukların D vitamini düzeyleri. Cukurova Medical Journal 2018;43:1-1. [DOI: 10.17826/cumj.365057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
77 Tablas MB, Goto RL, Caetano BFR, dos Santos SAA, Barbisan LF. Vitamin D3 suppresses the early stages of chemically induced hepatocarcinogenesis in rats: a dose-response analysis. Nutrire 2018;43:12. [DOI: 10.1186/s41110-018-0065-2] [Reference Citation Analysis]
78 Ruiz JL, François A. Primeros registros precisos de <em>Trox strandi</em> Balthasar, 1936 (Coleoptera: Trogidae) en Marruecos y observaciones sobre su hábitat y variabilidad morfológica. GRAELLSIA 2018;74:082. [DOI: 10.3989/graellsia.2018.v74.214] [Reference Citation Analysis]
79 Udomsinprasert W, Jittikoon J. Vitamin D and liver fibrosis: Molecular mechanisms and clinical studies. Biomed Pharmacother. 2019;109:1351-1360. [PMID: 30551386 DOI: 10.1016/j.biopha.2018.10.140] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 6.4] [Reference Citation Analysis]
80 Konstantinides P, Alexopoulou A, Hadziyannis E, Kanellopoulou T, Dourakis SP. Interleukin-17A and B-cell activating factor in chronic hepatitis C patients with or without asymptomatic mixed cryoglobulinemia: effects of antiviral treatment and correlations with vitamin D. Ann Gastroenterol 2018;31:705-11. [PMID: 30386121 DOI: 10.20524/aog.2018.0310] [Reference Citation Analysis]
81 Koop AH, Mousa OY, Pham LE, Corral-Hurtado JE, Pungpapong S, Keaveny AP. An Argument for Vitamin D, A, and Zinc Monitoring in Cirrhosis. Ann Hepatol 2018;17:920-32. [PMID: 30600288 DOI: 10.5604/01.3001.0012.7192] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
82 Ramadan HK, Makhlouf NA, Mahmoud AA, Abd Elrhman M, El-Masry MA. Role of vitamin D deficiency as a risk factor for infections in cirrhotic patients. Clin Res Hepatol Gastroenterol. 2019;43:51-57. [PMID: 30318356 DOI: 10.1016/j.clinre.2018.09.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
83 Mayr U, Fahrenkrog-Petersen L, Batres-Baires G, Rasch S, Herner A, Schmid RM, Huber W, Lahmer T. Vitamin D Deficiency Is Highly Prevalent in Critically Ill Patients and a Risk Factor for Mortality: A Prospective Observational Study Comparing Noncirrhotic Patients and Patients With Cirrhosis. J Intensive Care Med 2020;35:992-1001. [PMID: 30270710 DOI: 10.1177/0885066618803844] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
84 Warraich S, Sidhu A, Hou M, Alenezi O. The impact of Middle Eastern Origin, HIV, HCV, and HIV/HCV co-infection in the development of hypovitaminosis D in adults. Mol Genet Genomic Med 2018;6:1010-4. [PMID: 30209895 DOI: 10.1002/mgg3.475] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
85 Torun T, Çavuşoğlu H. D Vitamini Eksikliğine Bağlı Rikets ve Hemşirelik Bakımı. Hacettepe Üniversitesi Hemşirelik Fakültesi Dergisi 2018. [DOI: 10.31125/hunhemsire.454384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
86 Mou H, Yang F, Zhou J, Bao C. Correlation of liver function with intestinal flora, vitamin deficiency and IL-17A in patients with liver cirrhosis. Exp Ther Med 2018;16:4082-8. [PMID: 30344685 DOI: 10.3892/etm.2018.6663] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
87 Matsuda A, Ishiguro K, Yan IK, Patel T. Therapeutic Efficacy of Vitamin D in Experimental c-MET-β-Catenin-Driven Hepatocellular Cancer. Gene Expr 2019;19:151-9. [PMID: 30157994 DOI: 10.3727/105221618X15355518848281] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
88 Schiavo L, Busetto L, Cesaretti M, Zelber-Sagi S, Deutsch L, Iannelli A. Nutritional issues in patients with obesity and cirrhosis. World J Gastroenterol 2018; 24(30): 3330-3346 [PMID: 30122874 DOI: 10.3748/wjg.v24.i30.3330] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 43] [Article Influence: 8.6] [Reference Citation Analysis]
89 Wang J, Chen Y, Mo PL, Wei YJ, Liu KC, Zhang ZG, Zhang ZW, Chen XP, Zhang L. 1α,25-Dihydroxyvitamin D3 inhibits aflatoxin B1-induced proliferation and dedifferentiation of hepatic progenitor cells by regulating PI3K/Akt and Hippo pathways. J Steroid Biochem Mol Biol 2018;183:228-37. [PMID: 30099061 DOI: 10.1016/j.jsbmb.2018.08.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
90 Savić Ž, Vračarić V, Milić N, Nićiforović D, Damjanov D, Pellicano R, Medić-Stojanoska M, Abenavoli L. Vitamin D supplementation in patients with alcoholic liver cirrhosis: a prospective study. Minerva Med 2018;109:352-7. [PMID: 29963831 DOI: 10.23736/S0026-4806.18.05723-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
91 Abdel-Mohsen MA, El-Braky AA, Ghazal AAE, Shamseya MM. Autophagy, apoptosis, vitamin D, and vitamin D receptor in hepatocellular carcinoma associated with hepatitis C virus. Medicine (Baltimore) 2018;97:e0172. [PMID: 29561429 DOI: 10.1097/MD.0000000000010172] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
92 Lee WS, Jalaludin MY, Wong SY, Ong SY, Foo HW, Ng RT. Vitamin D non-sufficiency is prevalent in children with chronic liver disease in a tropical country. Pediatr Neonatol 2019;60:12-8. [PMID: 29680189 DOI: 10.1016/j.pedneo.2018.03.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
93 Kramer H, Syed D, Durazo-arvizu R, Camacho P, Hoofnagle A, Cotler S. Total 25-hydroxyvitamin D but not free 25-hydroxyvitamin D is associated with vitamin D binding globulin in adults with cirrhosis. EMIJ 2018;6. [DOI: 10.15406/emij.2018.06.00171] [Reference Citation Analysis]
94 Keane JT, Elangovan H, Stokes RA, Gunton JE. Vitamin D and the Liver-Correlation or Cause? Nutrients 2018;10:E496. [PMID: 29659559 DOI: 10.3390/nu10040496] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 10.8] [Reference Citation Analysis]
95 Lal BB, Alam S, Khanna R, Rawat D. Weekly regimen of vitamin D supplementation is more efficacious than stoss regimen for treatment of vitamin D deficiency in children with chronic liver diseases. Eur J Pediatr 2018;177:827-34. [PMID: 29504044 DOI: 10.1007/s00431-018-3123-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
96 Bahreynian M, Qorbani M, Motlagh ME, Heshmat R, Khademian M, Kelishadi R. Association of Serum 25-hydroxyvitamin D Levels and Liver Enzymes in a Nationally Representative Sample of Iranian Adolescents: The Childhood and Adolescence Surveillance and Prevention of Adult Noncommunicable Disease Study. Int J Prev Med 2018;9:24. [PMID: 29619148 DOI: 10.4103/ijpvm.IJPVM_37_18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
97 Czaja AJ. Epigenetic changes and their implications in autoimmune hepatitis. Eur J Clin Invest. 2018;48. [PMID: 29383703 DOI: 10.1111/eci.12899] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
98 Wu Y, Zeng Y, Wu W, Lin J, Ou Q. Polymorphisms of CYP27B1 are associated with IFN efficacy in HBeAg-positive patients. J Clin Lab Anal 2018;32:e22367. [PMID: 29457277 DOI: 10.1002/jcla.22367] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
99 Gayam V, Mandal AK, Khalid M, Mukhtar O, Gill A, Garlapati P, Tiongson B, Sherigar J, Mansour M, Mohanty S. Association Between Vitamin D Levels and Treatment Response to Direct-Acting Antivirals in Chronic Hepatitis C: A Real-World Study. Gastroenterology Res 2018;11:309-16. [PMID: 30116431 DOI: 10.14740/gr1072w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
100 Saberi B, Dadabhai AS, Nanavati J, Wang L, Shinohara RT, Mullin GE. Vitamin D levels do not predict the stage of hepatic fibrosis in patients with non-alcoholic fatty liver disease: A PRISMA compliant systematic review and meta-analysis of pooled data. World J Hepatol 2018; 10(1): 142-154 [PMID: 29399288 DOI: 10.4254/wjh.v10.i1.142] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
101 Bering T, Diniz KGD, Coelho MPP, Vieira DA, Soares MMS, Kakehasi AM, Correia MITD, Teixeira R, Queiroz DMM, Rocha GA, Silva LD. Association between pre-sarcopenia, sarcopenia, and bone mineral density in patients with chronic hepatitis C. J Cachexia Sarcopenia Muscle. 2018;9:255-268. [PMID: 29349902 DOI: 10.1002/jcsm.12269] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
102 Christopher KB. Vitamin D and Critically Ill Intensive Care Unit Patients. Vitamin D 2018. [DOI: 10.1016/b978-0-12-809963-6.00117-6] [Reference Citation Analysis]
103 Said E, Agawy WE, Ahmed R, Hassany M, Ahmed A, Fouad H, Baiumy H. Serum Vitamin D Levels in Treatment-naïve Chronic Hepatitis B Patients. J Transl Int Med 2017;5:230-4. [PMID: 29340280 DOI: 10.1515/jtim-2017-0038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
104 Walcott-Sapp S, Billingsley KG. Preoperative optimization for major hepatic resection. Langenbecks Arch Surg 2018;403:23-35. [PMID: 29150719 DOI: 10.1007/s00423-017-1638-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
105 Khayyatzadeh S, Vatanparast H, Avan A, Bagherniya M, Bahrami A, Kiani M, Bahrami-taghanaki H, Ferns G, Ghayour-mobarhan M. Serum Transaminase Concentrations and the Presence of Irritable Bowel Syndrome Are Associated with Serum 25-Hydroxy Vitamin D Concentrations in Adolescent Girls Who Are Overweight and Obese. Ann Nutr Metab 2018;71:234-41. [DOI: 10.1159/000484634] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
106 Bjelakovic G, Nikolova D, Bjelakovic M, Gluud C. Vitamin D supplementation for chronic liver diseases in adults. Cochrane Database Syst Rev. 2017;11:CD011564. [PMID: 29099543 DOI: 10.1002/14651858.cd011564.pub2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
107 Grant C. A vitamin D protocol post‐liver transplantation. Journal of the American Association of Nurse Practitioners 2017;29:658-66. [DOI: 10.1002/2327-6924.12503] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
108 Buonomo AR, Zappulo E, Scotto R, Pinchera B, Perruolo G, Formisano P, Borgia G, Gentile I. Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis. International Journal of Infectious Diseases 2017;63:23-9. [DOI: 10.1016/j.ijid.2017.07.026] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
109 Özerkan D, Özsoy N, Akbulut KG, Güney Ş, Öztürk G. The protective effect of vitamin D against carbon tetrachloride damage to the rat liver. Biotech Histochem 2017;92:513-23. [PMID: 28910170 DOI: 10.1080/10520295.2017.1361549] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
110 Jiang F, Yang Y, Xue L, Li B, Zhang Z. 1&#945;,25-dihydroxyvitamin D3 Attenuates TGF-&#946;-Induced Pro-Fibrotic Effects in Human Lung Epithelial Cells through Inhibition of Epithelial-Mesenchymal Transition. Nutrients 2017;9:E980. [PMID: 28878195 DOI: 10.3390/nu9090980] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
111 Grochocinski A, Dandalides A, Remley L. Nutrition for the Patient with Advanced Liver Disease. Curr Hepatology Rep 2017;16:205-211. [DOI: 10.1007/s11901-017-0354-x] [Reference Citation Analysis]
112 Komolmit P, Kimtrakool S, Suksawatamnuay S, Thanapirom K, Chattrasophon K, Thaimai P, Chirathaworn C, Poovorawan Y. Vitamin D supplementation improves serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients: A randomized, double-blind, placebo-controlled study. Sci Rep 2017;7:8905. [PMID: 28827788 DOI: 10.1038/s41598-017-09512-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
113 Jha AK, Jha SK, Kumar A, Dayal VM, Jha SK. Effect of replenishment of vitamin D on survival in patients with decompensated liver cirrhosis: A prospective study. World J Gastrointest Pathophysiol 2017; 8(3): 133-141 [PMID: 28868183 DOI: 10.4291/wjgp.v8.i3.133] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
114 Kim G, Kim KJ, Rhee Y, Lim SK. Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease. PLoS One 2017;12:e0182202. [PMID: 28759632 DOI: 10.1371/journal.pone.0182202] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
115 Ko BJ, Kim YS, Kim SG, Park JH, Lee SH, Jeong SW, Jang JY, Kim HS, Kim BS, Kim SM. Relationship between 25-Hydroxyvitamin D Levels and Liver Fibrosis as Assessed by Transient Elastography in Patients with Chronic Liver Disease. Gut Liver. 2016;10:818-825. [PMID: 27114415 DOI: 10.5009/gnl15331] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
116 Molfino A, Johnson S, Medici V. The Challenges of Nutritional Assessment in Cirrhosis. Curr Nutr Rep 2017;6:274-80. [PMID: 29201536 DOI: 10.1007/s13668-017-0216-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
117 Jaruvongvanich V, Ahuja W, Sanguankeo A, Wijarnpreecha K, Upala S. Vitamin D and histologic severity of nonalcoholic fatty liver disease: A systematic review and meta-analysis. Dig Liver Dis 2017;49:618-22. [PMID: 28274829 DOI: 10.1016/j.dld.2017.02.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
118 Kempinska-Podhorodecka A, Milkiewicz M, Jabłonski D, Milkiewicz P, Wunsch E. ApaI polymorphism of vitamin D receptor affects health-related quality of life in patients with primary sclerosing cholangitis. PLoS One 2017;12:e0176264. [PMID: 28426778 DOI: 10.1371/journal.pone.0176264] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
119 Thanapirom K, Suksawatamnuay S, Sukeepaisarnjaroen W, Tangkijvanich P, Treeprasertsuk S, Thaimai P, Wasitthankasem R, Poovorawan Y, Komolmit P. Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients. BMC Gastroenterol 2017;17:54. [PMID: 28415985 DOI: 10.1186/s12876-017-0613-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
120 Oliveira KS, Buss C, Tovo CV. Is there an association between vitamin D and liver fibrosis in patients with chronic hepatitis C? Arq Gastroenterol 2017;54:57-9. [PMID: 28079241 DOI: 10.1590/S0004-2803.2017v54n1-11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
121 Vidot H, Potter A, Cheng R, Allman-Farinelli M, Shackel N. Serum 25-hydroxyvitamin D deficiency and hepatic encephalopathy in chronic liver disease. World J Hepatol 2017; 9(10): 510-518 [PMID: 28443156 DOI: 10.4254/wjh.v9.i10.510] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
122 Hernández-Alvarez N, Pascasio Acevedo JM, Quintero E, Fernández Vázquez I, García-Eliz M, de la Revilla Negro J, Crespo García J, Hernández-Guerra M. Effect of season and sunlight on viral kinetics during hepatitis C virus therapy. BMJ Open Gastroenterol 2017;4:e000115. [PMID: 28321328 DOI: 10.1136/bmjgast-2016-000115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
123 Kempinska-Podhorodecka A, Milkiewicz M, Wasik U, Ligocka J, Zawadzki M, Krawczyk M, Milkiewicz P. Decreased Expression of Vitamin D Receptor Affects an Immune Response in Primary Biliary Cholangitis via the VDR-miRNA155-SOCS1 Pathway. Int J Mol Sci 2017;18:E289. [PMID: 28146070 DOI: 10.3390/ijms18020289] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 5.5] [Reference Citation Analysis]
124 Elangovan H, Chahal S, Gunton JE. Vitamin D in liver disease: Current evidence and potential directions.Biochim Biophys Acta Mol Basis Dis. 2017;1863:907-916. [PMID: 28064017 DOI: 10.1016/j.bbadis.2017.01.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
125 Dibb M. Nutritional Management of End-Stage Liver Disease. In Clinical Practice 2017. [DOI: 10.1007/978-3-319-43126-0_5] [Reference Citation Analysis]
126 Kumar R, Kumar P, Saxena KN, Mishra M, Mishra VK, Kumari A, Dwivedi M, Misra SP. Vitamin D status in patients with cirrhosis of the liver and their relatives-A case control study from North India. Indian J Gastroenterol 2017;36:50-5. [PMID: 28176238 DOI: 10.1007/s12664-017-0727-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
127 Yazdanpanah K, Sheykhesmeeili F, Parhizkar B, Ghasemi A. Serum Vitamin D Levels and Severity of Liver Dysfunction in Cirrhotic Patients. IJCM 2017;08:402-411. [DOI: 10.4236/ijcm.2017.86038] [Reference Citation Analysis]
128 Stokes CS, Volmer DA. Assessment of 3-epi-25-hydroxyvitamin D levels during cholecalciferol supplementation in adults with chronic liver diseases. Appl Physiol Nutr Metab 2016;41:1311-7. [DOI: 10.1139/apnm-2016-0196] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
129 Paternostro R, Wagner D, Reiberger T, Mandorfer M, Schwarzer R, Ferlitsch M, Trauner M, Peck-Radosavljevic M, Ferlitsch A. Low 25-OH-vitamin D levels reflect hepatic dysfunction and are associated with mortality in patients with liver cirrhosis. Wien Klin Wochenschr. 2017;129:8-15. [PMID: 27888359 DOI: 10.1007/s00508-016-1127-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
130 Montano-Loza AJ, Thandassery RB, Czaja AJ. Targeting Hepatic Fibrosis in Autoimmune Hepatitis. Dig Dis Sci 2016;61:3118-39. [PMID: 27435327 DOI: 10.1007/s10620-016-4254-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
131 Santos LA, Romeiro FG. Diagnosis and Management of Cirrhosis-Related Osteoporosis. Biomed Res Int. 2016;2016:1423462. [PMID: 27840821 DOI: 10.1155/2016/1423462] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
132 . UEG Week 2016 Poster Presentations. United European Gastroenterology Journal 2016;4:A157-720. [DOI: 10.1177/2050640616663689] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
133 Chinnaratha MA, Chaudhary S, Doogue M, McCormick RJ, Woodman RJ, Wigg AJ. Prevalence of hepatic osteodystrophy and vitamin D deficiency in cirrhosis. Intern Med J 2015;45:1230-5. [PMID: 26247615 DOI: 10.1111/imj.12866] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
134 Andrighetto LV, Dos Santos JS, Nicoletti G, Bock PM. INFLUÊNCIA DA VITAMINA D ASSOCIADA AO INTERFERON ALFA PEGUILADO E RIBAVIRINA NA RESPOSTA VIROLOGICA SUSTENTADA NA HEPATITE C CRÔNICA. Infarma 2016;28:140-148. [DOI: 10.14450/2318-9312.v28.e3.a2016.pp140-148] [Reference Citation Analysis]
135 Hoan NX, Khuyen N, Binh MT, Giang DP, Van Tong H, Hoan PQ, Trung NT, Anh DT, Toan NL, Meyer CG. Association of vitamin D deficiency with hepatitis B virus - related liver diseases. BMC Infect Dis. 2016;16:507. [PMID: 27659316 DOI: 10.1186/s12879-016-1836-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
136 Abdelsalam A, Rashed L, Salman T, Hammad L, Sabry D. Molecular assessment of vitamin D receptor polymorphism as a valid predictor to the response of interferon/ribavirin-based therapy in Egyptian patients with chronic hepatitis C. J Dig Dis 2016;17:547-53. [PMID: 27128845 DOI: 10.1111/1751-2980.12353] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
137 Colakoglu N, Kuloglu T, Ozan E, Kocaman N, Dabak DO, Parlak G. Protective effects of vitamin D3 against d-galactosamine-induced liver injury in rats. Tissue and Cell 2016;48:356-60. [DOI: 10.1016/j.tice.2016.05.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
138 Moroz L, Musaev EEO, Androsova O, Davydyuk I. VITAMIN D AS ONE OF PREDICATORS OF THE STABLE VIRAL RESPONSE TO ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIS HEPATITIS С. EUREKA: Health Sciences 2016;4:18-22. [DOI: 10.21303/2504-5679.2016.00117] [Reference Citation Analysis]
139 Zheng Z, Gelling RW. Attenuation of Carbon Tetrachloride-Induced Hepatic Toxicity by a Dietary Supplement. J Diet Suppl 2017;14:121-31. [PMID: 27471884 DOI: 10.1080/19390211.2016.1205702] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
140 Wahsh E, Abu-Elsaad N, El-Karef A, Ibrahim T. The vitamin D receptor agonist, calcipotriol, modulates fibrogenic pathways mitigating liver fibrosis in-vivo: An experimental study. Eur J Pharmacol. 2016;789:362-369. [PMID: 27477355 DOI: 10.1016/j.ejphar.2016.07.052] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
141 Chen J, Katz LH, Muñoz NM, Gu S, Shin JH, Jogunoori WS, Lee MH, Belkin MD, Kim SB, White JC, Andricovich J, Tzatsos A, Li S, Kim SS, Shetty K, Mishra B, Rashid A, Lee JS, Mishra L. Vitamin D Deficiency Promotes Liver Tumor Growth in Transforming Growth Factor-β/Smad3-Deficient Mice Through Wnt and Toll-like Receptor 7 Pathway Modulation. Sci Rep 2016;6:30217. [PMID: 27456065 DOI: 10.1038/srep30217] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
142 Belle A, Gizard E, Conroy G, Lopez A, Bouvier-Alias M, Rouanet S, Peyrin-Biroulet L, Pawlotsky JM, Bronowicki JP. 25-OH vitamin D level has no impact on the efficacy of antiviral therapy in naïve genotype 1 HCV-infected patients. United European Gastroenterol J 2017;5:69-75. [PMID: 28405324 DOI: 10.1177/2050640616640157] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
143 Kizilgul M, Ozcelik O, Delibasi T. Bone health and vitamin D status in alcoholic liver disease. Indian J Gastroenterol 2016;35:253-9. [PMID: 27246833 DOI: 10.1007/s12664-016-0652-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
144 Konstantakis C, Tselekouni P, Kalafateli M, Triantos C. Vitamin D deficiency in patients with liver cirrhosis. Ann Gastroenterol 2016;29:297-306. [PMID: 27366029 DOI: 10.20524/aog.2016.0037] [Cited by in Crossref: 23] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
145 D'Avolio A, Cusato J, De Nicolò A, Allegra S, Di Perri G. Pharmacogenetics of ribavirin-induced anemia in HCV patients. Pharmacogenomics 2016;17:925-41. [PMID: 27248282 DOI: 10.2217/pgs.16.22] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
146 Wintermeyer E, Ihle C, Ehnert S, Stöckle U, Ochs G, de Zwart P, Flesch I, Bahrs C, Nussler AK. Crucial Role of Vitamin D in the Musculoskeletal System. Nutrients 2016;8:E319. [PMID: 27258303 DOI: 10.3390/nu8060319] [Cited by in Crossref: 98] [Cited by in F6Publishing: 109] [Article Influence: 14.0] [Reference Citation Analysis]
147 Vosoghinia H, Esmaeilzadeh A, Ganji A, Hosseini SM, Jamehdar SA, Salehi M, Bahari A, Ghanaei O, Sahebari M, Rajabzadeh F, Ghaffarzadehgan K, Goshayeshi L. Vitamin D in Standard HCV Regimen (PEG-Interferon Plus Ribavirin), Its Effect on the Early Virologic Response Rate: A Clinical Trial. Razavi Int J Med 2016;4. [DOI: 10.17795/rijm36632] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
148 Fernández Fernández N, Linares Torres P, Joáo Matias D, Jorquera Plaza F, Olcoz Goñi JL. Vitamin D deficiency in chronic liver disease, clinical-epidemiological analysis and report after vitamin d supplementation. Gastroenterología y Hepatología (English Edition) 2016;39:305-310. [DOI: 10.1016/j.gastre.2016.04.007] [Reference Citation Analysis]
149 Wu M, Yue M, Huang P, Zhang Y, Xie C, Yu R, Li J, Wang J. Vitamin D level and vitamin D receptor genetic variations contribute to HCV infection susceptibility and chronicity in a Chinese population. Infect Genet Evol 2016;41:146-52. [PMID: 27063396 DOI: 10.1016/j.meegid.2016.03.032] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
150 Guarino M, Loperto I, Camera S, Cossiga V, Di Somma C, Colao A, Caporaso N, Morisco F. Osteoporosis across chronic liver disease. Osteoporos Int 2016;27:1967-77. [DOI: 10.1007/s00198-016-3512-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
151 Meyer A. Assessment of diet and recognition of nutritional deficiencies in paleopathological studies: A review. Clin Anat 2016;29:862-9. [PMID: 26823189 DOI: 10.1002/ca.22696] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
152 Anastácio LR, Davisson Correia MIT. Nutrition therapy: Integral part of liver transplant care. World J Gastroenterol 2016; 22(4): 1513-1522 [PMID: 26819518 DOI: 10.3748/wjg.v22.i4.1513] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
153 Sharifi N, Amani R, Hajiani E, Cheraghian B. Women may respond different from men to vitamin D supplementation regarding cardiometabolic biomarkers. Exp Biol Med (Maywood) 2016;241:830-8. [PMID: 26811103 DOI: 10.1177/1535370216629009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
154 Sheiko MA, Rosen HR. Hepatic Fibrosis in Hepatitis C. Hepatitis C Virus II 2016. [DOI: 10.1007/978-4-431-56101-9_3] [Reference Citation Analysis]
155 Amrein K, McNally JD, Dobnig H, Pieber TR. High-dose cholecalciferol in critically ill patients with liver cirrhosis. J Intern Med 2016;279:309-10. [PMID: 26707009 DOI: 10.1111/joim.12457] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
156 Fernández Fernández N, Linares Torres P, Joáo Matias D, Jorquera Plaza F, Olcoz Goñi JL. [Vitamin D deficiency in chronic liver disease, clinical-epidemiological analysis and report after vitamin d supplementation]. Gastroenterol Hepatol 2016;39:305-10. [PMID: 26596370 DOI: 10.1016/j.gastrohep.2015.10.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
157 Cusato J, Allegra S, Boglione L, De Nicolò A, Cariti G, Di Perri G, D'Avolio A. VDR gene polymorphisms impact on anemia at 2 weeks of anti-HCV therapy: a possible mechanism for early RBV-induced anemia. Pharmacogenet Genomics 2015;25:164-72. [PMID: 25713999 DOI: 10.1097/FPC.0000000000000123] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
158 Luo YQ, Wu XX, Ling ZX, Cheng YW, Yuan L, Xiang C. Association between serum vitamin D and severity of liver fibrosis in chronic hepatitis C patients: a systematic meta-analysis. J Zhejiang Univ Sci B. 2014;15:900-906. [PMID: 25294379 DOI: 10.1631/jzus.b1400073] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
159 Chan HL, Elkhashab M, Trinh H, Tak WY, Ma X, Chuang WL, Kim YJ, Martins EB, Lin L, Dinh P, Charuworn P, Foster GR, Marcellin P. Association of baseline vitamin D levels with clinical parameters and treatment outcomes in chronic hepatitis B. J Hepatol 2015;63:1086-92. [PMID: 26143444 DOI: 10.1016/j.jhep.2015.06.025] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 4.5] [Reference Citation Analysis]
160 Ren Y, Liu M, Zhao J, Ren F, Chen Y, Li JF, Zhang JY, Qu F, Zhang JL, Duan ZP, Zheng SJ. Serum vitamin D3 does not correlate with liver fibrosis in chronic hepatitis C. World J Gastroenterol 2015; 21(39): 11152-11159 [PMID: 26494969 DOI: 10.3748/wjg.v21.i39.11152] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
161 Reda R, Abbas AA, Mohammed M, El Fedawy SF, Ghareeb H, El Kabarity RH, Abo-Shady RA, Zakaria D. The Interplay between Zinc, Vitamin D and, IL-17 in Patients with Chronic Hepatitis C Liver Disease. J Immunol Res. 2015;2015:846348. [PMID: 26504859 DOI: 10.1155/2015/846348] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
162 Lai JC, Bikle DD, Lizaola B, Hayssen H, Terrault NA, Schwartz JB. Total 25(OH) vitamin D, free 25(OH) vitamin D and markers of bone turnover in cirrhotics with and without synthetic dysfunction. Liver Int 2015;35:2294-300. [PMID: 25757956 DOI: 10.1111/liv.12819] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
163 Kawazoe Y, Miyauchi M, Nagasaki A, Furusho H, Yanagisawa S, Chanbora C, Inubushi T, Hyogo H, Nakamoto T, Suzuki K, Moriwaki S, Tazuma S, Niida S, Takata T. Osteodystrophy in Cholestatic Liver Diseases Is Attenuated by Anti-γ-Glutamyl Transpeptidase Antibody. PLoS One 2015;10:e0139620. [PMID: 26418133 DOI: 10.1371/journal.pone.0139620] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
164 Coppola N, Pisaturo M, Sagnelli C, Onorato L, Sagnelli E. Role of genetic polymorphisms in hepatitis C virus chronic infection. World J Clin Cases 2015; 3(9): 807-822 [PMID: 26380828 DOI: 10.12998/wjcc.v3.i9.807] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
165 Rathi S, Dhiman RK. Hepatobiliary Quiz (Answers)-15 (2015). J Clin Exp Hepatol 2015;5:269-71. [PMID: 26628847 DOI: 10.1016/j.jceh.2015.08.008] [Reference Citation Analysis]
166 Fialho A, Fialho A, Kochhar G, Shen B. The presence of primary sclerosing cholangitis in patients with ileal pouch anal- anastomosis is associated with an additional risk for vitamin D deficiency. Gastroenterol Rep (Oxf) 2016;4:320-4. [PMID: 26290513 DOI: 10.1093/gastro/gov035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
167 Al Marzooqi SH, Feld JJ. Sorting out cirrhosis: mechanisms of non-response to hepatitis C therapy. Liver Int 2015;35:1923-33. [PMID: 25939775 DOI: 10.1111/liv.12861] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
168 Pontoriero AC, Trinks J, Hulaniuk ML, Caputo M, Fortuny L, Pratx LB, Frías A, Torres O, Nuñez F, Gadano A, Argibay P, Corach D, Flichman D. Influence of ethnicity on the distribution of genetic polymorphisms associated with risk of chronic liver disease in South American populations. BMC Genet 2015;16:93. [PMID: 26219465 DOI: 10.1186/s12863-015-0255-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
169 Stokes CS, Grünhage F, Baus C, Volmer DA, Wagenpfeil S, Riemenschneider M, Lammert F. Vitamin D supplementation reduces depressive symptoms in patients with chronic liver disease. Clin Nutr 2016;35:950-7. [PMID: 26212170 DOI: 10.1016/j.clnu.2015.07.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
170 Finkelmeier F, Kronenberger B, Zeuzem S, Piiper A, Waidmann O. Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis. PLoS One. 2015;10:e0132119. [PMID: 26121590 DOI: 10.1371/journal.pone.0132119] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
171 Lai JC, Shoback DM, Zipperstein J, Lizaola B, Tseng S, Terrault NA. Bone Mineral Density, Bone Turnover, and Systemic Inflammation in Non-cirrhotics with Chronic Hepatitis C. Dig Dis Sci 2015;60:1813-9. [PMID: 25563723 DOI: 10.1007/s10620-014-3507-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
172 Masri OA, Chalhoub JM, Sharara AI. Role of vitamins in gastrointestinal diseases. World J Gastroenterol 2015; 21(17): 5191-5209 [PMID: 25954093 DOI: 10.3748/wjg.v21.i17.5191] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
173 Beilfuss A, Sowa JP, Sydor S, Beste M, Bechmann LP, Schlattjan M, Syn WK, Wedemeyer I, Mathé Z, Jochum C, Gerken G, Gieseler RK, Canbay A. Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently. Gut 2015;64:791-9. [PMID: 25134788 DOI: 10.1136/gutjnl-2014-307024] [Cited by in Crossref: 90] [Cited by in F6Publishing: 86] [Article Influence: 11.3] [Reference Citation Analysis]
174 Berkan-Kawińska A, Koślińska-Berkan E, Piekarska A. The prevalence and severity of 25-(OH)-vitamin D insufficiency in HCV infected and in HBV infected patients: a prospective study. Clin Exp Hepatol 2015;1:5-11. [PMID: 28856249 DOI: 10.5114/ceh.2015.51373] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
175 Sum SS, Bruno M. The Link Between Vitamin D and Hepatitis B. Topics in Clinical Nutrition 2015;30:184-92. [DOI: 10.1097/tin.0000000000000030] [Reference Citation Analysis]
176 Wong GL, Chan HL, Chan HY, Tse CH, Chim AM, Lo AO, Wong VW. Adverse effects of vitamin D deficiency on outcomes of patients with chronic hepatitis B. Clin Gastroenterol Hepatol 2015;13:783-90.e1. [PMID: 25445773 DOI: 10.1016/j.cgh.2014.09.050] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 5.1] [Reference Citation Analysis]
177 Vaishya R, Vijay V, Agarwal AK, Jahangir J. Resurgence of vitamin D: Old wine in new bottle. J Clin Orthop Trauma 2015;6:173-83. [PMID: 26155053 DOI: 10.1016/j.jcot.2015.02.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
178 Bjelakovic G, Nikolova D, Bjelakovic M, Gluud C; Cochrane Hepato-Biliary Group. Vitamin D supplementation for chronic liver diseases in adults. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd011564] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
179 Boglione L, Cusato J, De Nicolò A, Cariti G, Di Perri G, D'Avolio A. Role of CYP27B1+2838 promoter polymorphism in the treatment of chronic hepatitis B HBeAg negative with PEG-interferon. J Viral Hepat 2015;22:318-27. [PMID: 25060765 DOI: 10.1111/jvh.12288] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
180 Bémeur C, Butterworth RF. Reprint of: Nutrition in the Management of Cirrhosis and its Neurological Complications. J Clin Exp Hepatol 2015;5:S131-40. [PMID: 26041952 DOI: 10.1016/j.jceh.2015.02.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
181 Reiter FP, Hohenester S, Nagel JM, Wimmer R, Artmann R, Wottke L, Makeschin MC, Mayr D, Rust C, Trauner M. 1,25-(OH)2-vitamin D3 prevents activation of hepatic stellate cells in vitro and ameliorates inflammatory liver damage but not fibrosis in the Abcb4(-/-) model. Biochem Biophys Res Commun. 2015;459:227-233. [PMID: 25712522 DOI: 10.1016/j.bbrc.2015.02.074] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
182 Sabry D, Al-Ghussein MA, Hamdy G, Abul-Fotouh A, Motawi T, El Kazaz AY, Eldemery A, Shaker M. Effect of vitamin D therapy on interleukin-6, visfatin, and hyaluronic acid levels in chronic hepatitis C Egyptian patients. Ther Clin Risk Manag 2015;11:279-88. [PMID: 25737638 DOI: 10.2147/TCRM.S66763] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
183 Collier J. Bone disorders. Cirrhosis: A practical guide to management 2015. [DOI: 10.1002/9781118412640.ch25] [Reference Citation Analysis]
184 Abramovitch S, Sharvit E, Weisman Y, Bentov A, Brazowski E, Cohen G, Volovelsky O, Reif S. Vitamin D inhibits development of liver fibrosis in an animal model but cannot ameliorate established cirrhosis. Am J Physiol Gastrointest Liver Physiol 2015;308:G112-20. [PMID: 25214398 DOI: 10.1152/ajpgi.00132.2013] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 6.4] [Reference Citation Analysis]
185 Costa Silva M, Erotides Silva T, de Alentar ML, Honório Coelho MS, Wildner LM, Bazzo ML, González-Chica DA, Dantas-Corrêa EB, Narciso-Schiavon JL, Schiavon Lde L. Factors associated with 25-hydroxyvitamin D levels in patients with liver cirrhosis. Ann Hepatol 2015;14:99-107. [PMID: 25536647] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
186 Iruzubieta P, Terán &, Crespo J, Fábrega E. Vitamin D deficiency in chronic liver disease. World J Hepatol 2014; 6(12): 901-915 [PMID: 25544877 DOI: 10.4254/wjh.v6.i12.901] [Cited by in Crossref: 63] [Cited by in F6Publishing: 69] [Article Influence: 7.0] [Reference Citation Analysis]
187 Chen EQ, Shi Y, Tang H. New insight of vitamin D in chronic liver diseases. Hepatobiliary Pancreat Dis Int 2014;13:580-5. [PMID: 25475859 DOI: 10.1016/s1499-3872(14)60295-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
188 García-Álvarez M, Pineda-Tenor D, Jiménez-Sousa MA, Fernández-Rodríguez A, Guzmán-Fulgencio M, Resino S. Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: a meta-analysis. Hepatology 2014;60:1541-50. [PMID: 24975775 DOI: 10.1002/hep.27281] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 6.4] [Reference Citation Analysis]
189 Gerova DI, Galunska BT, Ivanova II, Kotzev IA, Tchervenkov TG, Balev SP, Svinarov DA. Prevalence of vitamin D deficiency and insufficiency in Bulgarian patients with chronic hepatitis C viral infection. Scand J Clin Lab Invest. 2014;74:665-672. [PMID: 25005344 DOI: 10.3109/00365513.2014.930710] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
190 Hochrath K, Stokes CS, Geisel J, Pollheimer MJ, Fickert P, Dooley S, Lammert F. Vitamin D modulates biliary fibrosis in ABCB4-deficient mice. Hepatol Int 2014;8:443-52. [PMID: 25191532 DOI: 10.1007/s12072-014-9548-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
191 Mohammed MA, Omar NM, Mansour AH, Abd El-azi SM, Othman G. 25-Hydroxyvitamin D3 Level in Patients with Chronic Viral Hepatitis B. J of Medical Sciences 2014;14:192-200. [DOI: 10.3923/jms.2014.192.200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
192 Bémeur C, Butterworth RF. Nutrition in the management of cirrhosis and its neurological complications. J Clin Exp Hepatol 2014;4:141-50. [PMID: 25755550 DOI: 10.1016/j.jceh.2013.05.008] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 6.2] [Reference Citation Analysis]
193 Finkelmeier F, Kronenberger B, Köberle V, Bojunga J, Zeuzem S, Trojan J, Piiper A, Waidmann O. Severe 25-hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma - a prospective cohort study. Aliment Pharmacol Ther 2014;39:1204-12. [PMID: 24684435 DOI: 10.1111/apt.12731] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 6.2] [Reference Citation Analysis]
194 Kong J, Ding Y, Zhang C, Fu Y, Du J, Lu C, Dou X, Chen Y, Li YC, Zhao Q. Severe vitamin D-deficiency and increased bone turnover in patients with hepatitis B from northeastern China. Endocr Res 2013;38:215-22. [PMID: 24073717 DOI: 10.3109/07435800.2013.768266] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
195 Kwarta E, Nagle S, Welstead L. Update on Malnutrition in Liver Cirrhosis: Assessment and Treatment. Curr Hepatology Rep 2014;13:24-34. [DOI: 10.1007/s11901-014-0230-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
196 Zhao J, Zheng SJ. Role of vitamin D in liver diseases. Shijie Huaren Xiaohua Zazhi 2014; 22(9): 1214-1218 [DOI: 10.11569/wcjd.v22.i9.1214] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
197 Skaaby T, Husemoen LL, Linneberg A. Does liver damage explain the inverse association between vitamin D status and mortality? Ann Epidemiol 2013;23:812-4. [PMID: 24404569 DOI: 10.1016/j.annepidem.2013.10.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
198 Nobili V, Giorgio V, Liccardo D, Bedogni G, Morino G, Alisi A, Cianfarani S. Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease. Eur J Endocrinol. 2014;170:547-553. [PMID: 24412930 DOI: 10.1530/eje-13-0609] [Cited by in Crossref: 71] [Cited by in F6Publishing: 75] [Article Influence: 7.9] [Reference Citation Analysis]
199 Grammatikos G, Lange C, Susser S, Schwendy S, Dikopoulos N, Buggisch P, Encke J, Teuber G, Goeser T, Thimme R. Vitamin D levels vary during antiviral treatment but are unable to predict treatment outcome in HCV genotype 1 infected patients. PLoS One. 2014;9:e87974. [PMID: 24516573 DOI: 10.1371/journal.pone.0087974] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
200 Amanzada A, Goralczyk AD, Moriconi F, van Thiel DH, Ramadori G, Mihm S. Vitamin D status and serum ferritin concentration in chronic hepatitis C virus type 1 infection. J Med Virol. 2013;85:1534-1541. [PMID: 23852677 DOI: 10.1002/jmv.23632] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
201 Nussler AK, Wildemann B, Freude T, Litzka C, Soldo P, Friess H, Hammad S, Hengstler JG, Braun KF, Trak-Smayra V, Godoy P, Ehnert S. Chronic CCl4 intoxication causes liver and bone damage similar to the human pathology of hepatic osteodystrophy: a mouse model to analyse the liver-bone axis. Arch Toxicol 2014;88:997-1006. [PMID: 24381012 DOI: 10.1007/s00204-013-1191-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
202 Gutierrez JA, Jones KA, Flores R, Singhania A, Woelk CH, Schooley RT, Wyles DL. Vitamin D Metabolites Inhibit Hepatitis C Virus and Modulate Cellular Gene Expression. J Virol Antivir Res. 2014;3. [PMID: 26594646 DOI: 10.4172/2324-8955.1000129] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
203 Grünhage F, Mahler M, Reichel C, Lammert F. Extremely low vitamin d levels are associated with increased mortality in patients with liver cirrhosis. J Hepatol. 2012;56:S247. [PMID: 24236541 DOI: 10.1111/eci.12205] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
204 Abu Shady MM, Nassef YE, Mansour M, Galal EM, Hamed MA. Evaluation of the role of vitamin D levels in predicting chronic liver disease development in a group of Egyptian children infected with the hepatitis C virus. Medical Research Journal 2013;12:69-75. [DOI: 10.1097/01.mjx.0000437953.50631.0c] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
205 Skaaby T, Husemoen LL, Borglykke A, Jørgensen T, Thuesen BH, Pisinger C, Schmidt LE, Linneberg A. Vitamin D status, liver enzymes, and incident liver disease and mortality: a general population study. Endocrine 2014;47:213-20. [PMID: 24272594 DOI: 10.1007/s12020-013-0107-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
206 Meer AJ, Maan R, Knegt RJ, Veldt BJ. Natural History of HCV-induced Liver Disease. Curr Hepatitis Rep 2013;12:251-60. [DOI: 10.1007/s11901-013-0195-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
207 Guzmán-Fulgencio M, García-Álvarez M, Berenguer J, Jiménez-Sousa MÁ, Cosín J, Pineda-Tenor D, Carrero A, Aldámiz T, Alvarez E, López JC, Resino S. Vitamin D deficiency is associated with severity of liver disease in HIV/HCV coinfected patients. J Infect. 2014;68:176-184. [PMID: 24184809 DOI: 10.1016/j.jinf.2013.10.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
208 Villar LM, Del Campo JA, Ranchal I, Lampe E, Romero-Gomez M. Association between vitamin D and hepatitis C virus infection: A meta-analysis. World J Gastroenterol 2013; 19(35): 5917-5924 [PMID: 24124339 DOI: 10.3748/wjg.v19.i35.5917] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 67] [Article Influence: 6.5] [Reference Citation Analysis]
209 García-Martín E, Agúndez JA, Maestro ML, Suárez A, Vidaurreta M, Martínez C, Fernández-Pérez C, Ortega L, Ladero JM. Influence of vitamin D-related gene polymorphisms (CYP27B and VDR) on the response to interferon/ribavirin therapy in chronic hepatitis C. PLoS One. 2013;8:e74764. [PMID: 24073221 DOI: 10.1371/journal.pone.0074764] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
210 Morisco F, Colao A, Guarino M, Lembo V, Granata R, Donnarumma L, Auriemma F, Mariniello A, Mazzone G, Di Somma C, Rubino M, Cariati F, Pivonello C, Loperto I, Caporaso N. Vitamin D levels and chronic hepatitis C. e-SPEN Journal 2013;8:e169-74. [DOI: 10.1016/j.clnme.2013.04.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
211 Smyk DS, Orfanidou T, Invernizzi P, Bogdanos DP, Lenzi M. Vitamin D in autoimmune liver disease. Clin Res Hepatol Gastroenterol. 2013;37:535-545. [PMID: 23845396 DOI: 10.1016/j.clinre.2013.05.016] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
212 Thiem U, Olbramski B, Borchhardt K. Calcidiol deficiency in end-stage organ failure and after solid organ transplantation: status quo. Nutrients 2013;5:2352-71. [PMID: 23857217 DOI: 10.3390/nu5072352] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
213 Zhu M, Xu LM. Relationship between vitamin D and chronic liver diseases. Shijie Huaren Xiaohua Zazhi 2013; 21(18): 1714-1719 [DOI: 10.11569/wcjd.v21.i18.1714] [Reference Citation Analysis]
214 Venu M, Martin E, Saeian K, Gawrieh S. High prevalence of vitamin A deficiency and vitamin D deficiency in patients evaluated for liver transplantation. Liver Transpl 2013;19:627-33. [PMID: 23495130 DOI: 10.1002/lt.23646] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 4.4] [Reference Citation Analysis]
215 Zeanandin G, Thibault R, Bachmann P, Coti-bertrand P, Guex E, Quilliot D. Prise en charge nutritionnelle d’un patient cirrhotique. Nutrition Clinique et Métabolisme 2013;27:102-104. [DOI: 10.1016/j.nupar.2013.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
216 Huang WH, Yu MC, Huang JY, Lai PC. Impact of hepatitis C virus infection on bone mineral density in renal transplant recipients. PLoS One. 2013;8:e63263. [PMID: 23675468 DOI: 10.1371/journal.pone.0063263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
217 Potter JJ, Liu X, Koteish A, Mezey E. 1,25-dihydroxyvitamin D3 and its nuclear receptor repress human α1 (I) collagen expression and type I collagen formation. Liver Int 2013;33:677-86. [PMID: 23413886 DOI: 10.1111/liv.12122] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
218 Song BJ, Rockey DC. Status of research on vitamin D supplementation in treating or preventing liver fibrosis. Liver Int 2013;33:653-5. [PMID: 23560728 DOI: 10.1111/liv.12147] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
219 Kitson MT, Dore GJ, George J, Button P, McCaughan GW, Crawford DH, Sievert W, Weltman MD, Cheng WS, Roberts SK. Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection. J Hepatol 2013;58:467-72. [PMID: 23183524 DOI: 10.1016/j.jhep.2012.11.017] [Cited by in Crossref: 55] [Cited by in F6Publishing: 60] [Article Influence: 5.5] [Reference Citation Analysis]
220 Zhu Q, Li N, Han Q, Li Z, Zhang G, Li F, Zhang P, Chen J, Lv Y, Liu Z. Single-nucleotide polymorphism at CYP27B1-1260, but not VDR Taq I, is possibly associated with persistent hepatitis B virus infection. Genet Test Mol Biomarkers 2012;16:1115-21. [PMID: 22963605 DOI: 10.1089/gtmb.2012.0148] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
221 Johnson TM, Overgard EB, Cohen AE, Dibaise JK. Nutrition Assessment and Management in Advanced Liver Disease. Nutr Clin Pract 2013;28:15-29. [DOI: 10.1177/0884533612469027] [Cited by in Crossref: 95] [Cited by in F6Publishing: 105] [Article Influence: 9.5] [Reference Citation Analysis]
222 Yadav A, Carey EJ. Osteoporosis in chronic liver disease. Nutr Clin Pract. 2013;28:52-64. [PMID: 23263929 DOI: 10.1177/0884533612470145] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
223 Skaaby T, Husemoen LL, Pisinger C, Jørgensen T, Thuesen BH, Fenger M, Linneberg A. Vitamin D status and cause-specific mortality: a general population study. PLoS One 2012;7:e52423. [PMID: 23285034 DOI: 10.1371/journal.pone.0052423] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
224 Bartley J, Camargo C. Vitamin D and Infection. Oxidative Stress and Disease 2012. [DOI: 10.1201/b13714-17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
225 Falleti E, Bitetto D, Fabris C, Fattovich G, Cussigh A, Cmet S, Ceriani E, Fornasiere E, Pasino M, Ieluzzi D, Pirisi M, Toniutto P. Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C. Hepatology 2012;56:1641-50. [PMID: 22610885 DOI: 10.1002/hep.25848] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 4.9] [Reference Citation Analysis]
226 Grünhage F, Hochrath K, Krawczyk M, Höblinger A, Obermayer-Pietsch B, Geisel J, Trauner M, Sauerbruch T, Lammert F. Common genetic variation in vitamin D metabolism is associated with liver stiffness. Hepatology 2012;56:1883-91. [PMID: 22576297 DOI: 10.1002/hep.25830] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
227 Lương KVQ, Nguyễn LTH. Theoretical basis of a beneficial role for vitamin D in viral hepatitis. World J Gastroenterol 2012; 18(38): 5338-5350 [PMID: 23082050 DOI: 10.3748/wjg.v18.i38.5338] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
228 Kitson MT, Roberts SK. D-livering the message: the importance of vitamin D status in chronic liver disease. J Hepatol 2012;57:897-909. [PMID: 22634121 DOI: 10.1016/j.jhep.2012.04.033] [Cited by in Crossref: 150] [Cited by in F6Publishing: 152] [Article Influence: 13.6] [Reference Citation Analysis]
229 Weintraub SJ, Fleckenstein JF, Marion TN, Madey MA, Mahmoudi TM, Schechtman KB. Vitamin D and the racial difference in the genotype 1 chronic hepatitis C treatment response. Am J Clin Nutr 2012;96:1025-31. [PMID: 23015322 DOI: 10.3945/ajcn.112.039974] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
230 Myers RP, Ramji A, Bilodeau M, Wong S, Feld JJ. An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver. Can J Gastroenterol 2012;26:359-75. [PMID: 22720279 DOI: 10.1155/2012/947676] [Cited by in Crossref: 43] [Cited by in F6Publishing: 64] [Article Influence: 3.9] [Reference Citation Analysis]
231 El Husseiny NM, Fahmy HM, Mohamed WA, Amin HH. Relationship between vitamin D and IL-23, IL-17 and macrophage chemoattractant protein-1 as markers of fibrosis in hepatitis C virus Egyptians. World J Hepatol 2012; 4(8): 242-247 [PMID: 22993666 DOI: 10.4254/wjh.v4.i8.242] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
232 Schaalan MF, Mohamed WA, Amin HH. Vitamin D deficiency: Correlation to interleukin-17, interleukin-23 and PIIINP in hepatitis C virus genotype 4. World J Gastroenterol 2012; 18(28): 3738-3744 [PMID: 22851868 DOI: 10.3748/wjg.v18.i28.3738] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
233 Chatrath H, Liangpunsakul S, Ghabril M, Otte J, Chalasani N, Vuppalanchi R. Prevalence and morbidity associated with muscle cramps in patients with cirrhosis. Am J Med. 2012;125:1019-1025. [PMID: 22835465 DOI: 10.1016/j.amjmed.2012.03.012] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 4.1] [Reference Citation Analysis]
234 Mcclain CJ, Hill DB, Marsano L. Liver Disease. Present Knowledge in Nutrition 2012. [DOI: 10.1002/9781119946045.ch54] [Reference Citation Analysis]
235 Antico A, Tampoia M, Tozzoli R, Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev. 2012;12:127-136. [PMID: 22776787 DOI: 10.1016/j.autrev.2012.07.007] [Cited by in Crossref: 188] [Cited by in F6Publishing: 199] [Article Influence: 17.1] [Reference Citation Analysis]
236 Putz-Bankuti C, Pilz S, Stojakovic T, Scharnagl H, Pieber TR, Trauner M, Obermayer-Pietsch B, Stauber RE. Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease. Liver Int 2012;32:845-51. [PMID: 22222013 DOI: 10.1111/j.1478-3231.2011.02735.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 84] [Article Influence: 7.1] [Reference Citation Analysis]
237 Lim LY, Chalasani N. Vitamin d deficiency in patients with chronic liver disease and cirrhosis. Curr Gastroenterol Rep. 2012;14:67-73. [PMID: 22113744 DOI: 10.1007/s11894-011-0231-7] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 3.8] [Reference Citation Analysis]
238 Baur K, Mertens JC, Schmitt J, Iwata R, Stieger B, Eloranta JJ, Frei P, Stickel F, Dill MT, Seifert B, Ferrari HA, von Eckardstein A, Bochud PY, Müllhaupt B, Geier A; Swiss Hepatitis C Cohort Study Group. Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patients. Liver Int 2012;32:635-43. [PMID: 22151003 DOI: 10.1111/j.1478-3231.2011.02674.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 70] [Article Influence: 6.4] [Reference Citation Analysis]
239 Cholongitas E, Theocharidou E, Goulis J, Tsochatzis E, Akriviadis E, Burroughs K. Review article: the extra-skeletal effects of vitamin D in chronic hepatitis C infection. Aliment Pharmacol Ther 2012;35:634-46. [PMID: 22316435 DOI: 10.1111/j.1365-2036.2012.05000.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
240 Nimer A, Mouch A. Vitamin D improves viral response in hepatitis C genotype 2-3 naïve patients. World J Gastroenterol 2012; 18(8): 800-805 [PMID: 22371640 DOI: 10.3748/wjg.v18.i8.800] [Cited by in CrossRef: 103] [Cited by in F6Publishing: 114] [Article Influence: 9.4] [Reference Citation Analysis]
241 Cheung K, Lee SS, Raman M. Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies. Clin Gastroenterol Hepatol 2012;10:117-25. [PMID: 21893127 DOI: 10.1016/j.cgh.2011.08.016] [Cited by in Crossref: 200] [Cited by in F6Publishing: 164] [Article Influence: 18.2] [Reference Citation Analysis]
242 Mansueto P, Carroccio A, Seidita A, Di Fede G, Craxì A. Osteodystrophy in chronic liver diseases. Intern Emerg Med 2013;8:377-88. [PMID: 22241574 DOI: 10.1007/s11739-012-0753-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
243 Kim SH, Yang TU, Choi BK, Yoo HJ, Seo JA, Choi KM, Kim NH, Kim SG, Baik SH, Choi DS, Choi HY. A Case of Multiple Osteoporotic Compression Fractures in Young Man with Budd-Chiari Syndrome. Endocrinol Metab 2012;27:334. [DOI: 10.3803/enm.2012.27.4.334] [Reference Citation Analysis]
244 Zhang C, Zhao L, Ma L, Lv C, Ding Y, Xia T, Wang J, Dou X. Vitamin D status and expression of vitamin D receptor and LL-37 in patients with spontaneous bacterial peritonitis. Dig Dis Sci 2012;57:182-8. [PMID: 21755299 DOI: 10.1007/s10620-011-1824-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
245 López-Larramona G, Lucendo AJ, González-Castillo S, Tenias JM. Hepatic osteodystrophy: An important matter for consideration in chronic liver disease. World J Hepatol 2011; 3(12): 300-307 [PMID: 22216370 DOI: 10.4254/wjh.v3.i12.300] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 4.3] [Reference Citation Analysis]
246 Gutierrez JA, Parikh N, Branch AD. Classical and emerging roles of vitamin D in hepatitis C virus infection. Semin Liver Dis. 2011;31:387-398. [PMID: 22189978 DOI: 10.1055/s-0031-1297927] [Cited by in Crossref: 54] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
247 Abu-Mouch S, Fireman Z, Jarchovsky J, Zeina AR, Assy N. Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients. World J Gastroenterol 2011; 17(47): 5184-5190 [PMID: 22215943 DOI: 10.3748/wjg.v17.i47.5184] [Cited by in CrossRef: 150] [Cited by in F6Publishing: 161] [Article Influence: 12.5] [Reference Citation Analysis]
248 Rudic JS, Poropat G, Krstic MN, Bjelakovic G, Gluud C. Hormone replacement for osteoporosis in women with primary biliary cirrhosis. Cochrane Database Syst Rev. 2011;CD009146. [PMID: 22161447 DOI: 10.1002/14651858.cd009146.pub2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
249 Gal-Tanamy M, Bachmetov L, Ravid A, Koren R, Erman A, Tur-Kaspa R, Zemel R. Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes. Hepatology 2011;54:1570-9. [PMID: 21793032 DOI: 10.1002/hep.24575] [Cited by in Crossref: 124] [Cited by in F6Publishing: 122] [Article Influence: 10.3] [Reference Citation Analysis]
250 Bitetto D, Fabris C, Falleti E, Toniutto P. Vitamin D deficiency and HCV chronic infection: what comes first? J Hepatol 2011;55:944-5; author reply 945. [PMID: 21349298 DOI: 10.1016/j.jhep.2011.01.044] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
251 Rudic JS, Poropat G, Krstic MN, Bjelakovic G, Gluud C. Hormone replacement for osteoporosis in women with primary biliary cirrhosis. Cochrane Database of Systematic Reviews 2011. [DOI: 10.1002/14651858.cd009146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
252 Lange CM, Bojunga J, Ramos-Lopez E, von Wagner M, Hassler A, Vermehren J, Herrmann E, Badenhoop K, Zeuzem S, Sarrazin C. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. J Hepatol 2011;54:887-93. [PMID: 21145801 DOI: 10.1016/j.jhep.2010.08.036] [Cited by in Crossref: 178] [Cited by in F6Publishing: 192] [Article Influence: 14.8] [Reference Citation Analysis]
253 Sultan MI, Leon CD, Biank VF. Role of nutrition in pediatric chronic liver disease. Nutr Clin Pract. 2011;26:401-408. [PMID: 21531738 DOI: 10.1177/0884533611405535] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
254 Bitetto D, Fattovich G, Fabris C, Ceriani E, Falleti E, Fornasiere E, Pasino M, Ieluzzi D, Cussigh A, Cmet S, Pirisi M, Toniutto P. Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C. Hepatology 2011;53:1118-26. [PMID: 21480318 DOI: 10.1002/hep.24201] [Cited by in Crossref: 102] [Cited by in F6Publishing: 99] [Article Influence: 8.5] [Reference Citation Analysis]
255 O'malley T, Heuberger R. Vitamin D status and supplementation in pediatric gastrointestinal disease: Vitamin D Status and Supplementation in Pediatric Gastrointestinal Disease. Journal for Specialists in Pediatric Nursing 2011;16:140-50. [DOI: 10.1111/j.1744-6155.2011.00280.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
256 Zúñiga S, Firrincieli D, Housset C, Chignard N. Vitamin D and the vitamin D receptor in liver pathophysiology. Clin Res Hepatol Gastroenterol 2011;35:295-302. [PMID: 21440524 DOI: 10.1016/j.clinre.2011.02.003] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 3.5] [Reference Citation Analysis]
257 Fiorino S, Conti F, Gramenzi A, Loggi E, Cursaro C, Di Donato R, Micco L, Gitto S, Cuppini A, Bernardi M, Andreone P. Vitamins in the treatment of chronic viral hepatitis. Br J Nutr 2011;105:982-9. [PMID: 21255469 DOI: 10.1017/S0007114510004629] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
258 Abdel-Ghaffar TY, Behairy EB, Abd El-Shaheed A, Mahdy K, El-Batanony M, Hussein MH, Sira MM. Clinical Benefits of Biochemical Markers of Fibrosis in Egyptian Children With Chronic Liver Diseases. Gastroenterol Res. 2010;3:262-271. [PMID: 27942306 DOI: 10.4021/gr246w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
259 Kriegel MA, Manson JE, Costenbader KH. Does vitamin D affect risk of developing autoimmune disease?: a systematic review. Semin Arthritis Rheum 2011;40:512-531.e8. [PMID: 21047669 DOI: 10.1016/j.semarthrit.2010.07.009] [Cited by in Crossref: 109] [Cited by in F6Publishing: 119] [Article Influence: 8.4] [Reference Citation Analysis]
260 Al-chalabi A, Kreymann B, Huber W. Leberunterstützungstherapien 2010. Intensivmed 2010;47:576-581. [DOI: 10.1007/s00390-010-0194-1] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
261 Selmi C, Mackay IR, Gershwin ME. The autoimmunity of primary biliary cirrhosis and the clonal selection theory. Immunol Cell Biol 2011;89:70-80. [PMID: 20975735 DOI: 10.1038/icb.2010.126] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
262 Miheller P, Lakatos PL, Tóth M. Bone Homeostasis in Intestinal Disorders. Clinic Rev Bone Miner Metab 2010;8:140-148. [DOI: 10.1007/s12018-010-9069-z] [Reference Citation Analysis]